Not Signed In -
Azelastine Nasal Spray |
Astelin |
Clinical Trial: Treatment for Smoking
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to see how people like the nicotine medications and to see if the treatment given helps people quit smoking.
Hypothesis: Combining nicotine reduction therapies, tailoring treatment and adding training can significantly reduce early drop-out and slips responsible for relapse and low outcome rates in smoking cessation.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Smoking | Drug: patch Drug: nasal spray Drug: inhaler Drug: gum | Phase I |
MedlinePlus related topics: Smoking
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study
Official Title: Nicotine Delivery Systems: Research and Treatment
Study start: October 2002; Expected completion: September 2006
Eligibility
Ages Eligible for Study: 25 Years - 55 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
Exclusion Criteria:
Location and Contact Information
California
VA Greater Los Angeles Healthcare System, Los Angeles, California, 90073, United States; Recruiting
Nina G. Schneider, Ph.D., Principal Investigator
More Information
Record last reviewed: April 2005
Last Updated: April 14, 2005
Record first received: April 14, 2005
ClinicalTrials.gov Identifier: NCT00108342
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-05-03
Source: ClinicalTrials.gov
Cache Date: May 4, 2005
Resources
- Astelin (Drug Digest)
- Azelastine Nasal Spray (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
